Cargando…
Addressing COVID‐19 Drug Development with Artificial Intelligence
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that led to the COVID‐19 (Coronavirus Disease 2019) pandemic, has resulted in substantial overburdening of healthcare systems as well as an economic crisis on a global scale. This has in turn resulted in widespr...
Autor principal: | Ho, Dean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235485/ https://www.ncbi.nlm.nih.gov/pubmed/32838299 http://dx.doi.org/10.1002/aisy.202000070 |
Ejemplares similares
-
Artificial Intelligence‐Based Clinical Decision Support for COVID‐19–Where Art Thou?
por: Unberath, Mathias, et al.
Publicado: (2020) -
Real-world application, challenges and implication of artificial intelligence in healthcare: an essay
por: Mudgal, Shiv Kumar, et al.
Publicado: (2022) -
Address on Artificial Dentures
por: Allen, J.
Publicado: (1858) -
Task-sharing with artificial intelligence: a design hypothesis for an Emergency Unit in sub-Saharan Africa
por: Lamanna, Camillo
Publicado: (2021) -
Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities
por: Katikireddi, Srinivasa Vittal, et al.
Publicado: (2021)